文献速递血栓与止血

甲状腺功能对凝血系统的影响及其临床后果

The influence of thyroid function on the coagulation system and its clinical consequences.
PubMed 文献 · J Thromb Haemost · 2018-03-23

综述讨论甲状腺激素水平对止血系统的影响:甲状腺激素水平低使止血系统向低凝和纤溶亢进状态偏移,水平高则导致凝血增强和纤溶减弱;低水平似乎增加出血风险,高水平增加静脉血栓栓塞风险。甲状腺功能减退者获得性von Willebrand综合征发生率更高,随游离甲状腺素水平升高,纤维蛋白原、因子VIII和von Willebrand因子等水平逐渐升高,在甲状腺功能亢进患者中可能导致症状性静脉血栓栓塞。作者认为甲状腺功能减退患者出血并发症风险增加,尤其在接受侵入性操作时;医生应警惕甲状腺功能亢进作为静脉血栓栓塞的潜在危险因素,尤其是不明原因病例;需要临床研究进一步探究这些发现对一般实践的意义。

要点

  • 甲状腺激素水平低使止血系统向低凝和纤溶亢进状态偏移,似乎增加出血风险。
  • 甲状腺激素水平高导致凝血增强和纤溶减弱,增加静脉血栓栓塞风险。
  • 甲状腺功能减退者获得性von Willebrand综合征发生率更高,接受侵入性操作时出血风险增加。

核心结论

  • 甲状腺激素水平低似乎导致出血风险增加,水平高则增加静脉血栓栓塞风险。
  • 甲状腺功能减退患者出血并发症风险增加,在接受侵入性操作时可能相关。
  • 医生应警惕甲状腺功能亢进作为静脉血栓栓塞的潜在危险因素,尤其是不明原因病例。
  • 需要临床研究进一步探究这些发现对一般实践的意义。

研究设计与样本

  • 综述讨论甲状腺激素对止血系统影响的文献及相关出血和静脉血栓栓塞风险。

主要发现

  • 甲状腺激素水平低使止血系统向低凝和纤溶亢进状态偏移,水平高导致凝血增强和纤溶减弱。
  • 甲状腺功能减退者获得性von Willebrand综合征发生率更高。
  • 随游离甲状腺素水平升高,纤维蛋白原、因子VIII和von Willebrand因子等水平逐渐升高,在甲状腺功能亢进患者中可能导致症状性静脉血栓栓塞。
  • 除对静脉血栓栓塞的影响外,还描述了甲状腺功能亢进对心房颤动所致栓塞的影响。

临床怎么用

  • 甲状腺功能减退患者出血并发症风险增加,在接受侵入性操作时可能需考虑此风险。
  • 医生应警惕甲状腺功能亢进作为静脉血栓栓塞的潜在危险因素,尤其是不明原因病例。

局限性

  • 需要临床研究进一步探究这些发现对一般实践的意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several studies indicate that low plasma levels of thyroid hormone shift the hemostatic system towards a hypocoagulable and hyperfibrinolytic state, whereas high levels of thyroid hormone lead to more coagulation and less fibrinolysis. Low levels of thyroid hormone thereby seem to lead to an increased bleeding risk, whereas high levels, by contrast, increase the risk of venous thromboembolism. Hypothyroidism leads to a higher incidence of acquired von Willebrand's syndrome and with increasing levels of free thyroxine, levels of fibrinogen, factor VIII and von Willebrand factor, amongst others, increase gradually, to the extent that they may lead to symptomatic venous thromboembolism in patients with hyperthyroidism. Here, we discuss the literature on the effect of thyroid hormone on the hemostatic system and the associated risk of bleeding and venous thromboembolism. Patients with hypothyroidism are at increased risk of developing bleeding complications, which could be relevant in patients undergoing invasive procedures. Furthermore, physicians should be aware of the possibility of hyperthyroidism as an underlying risk factor for venous thromboembolism, especially in unexplained cases. Clinical studies are needed to further investigate the significance for general practice of these findings. Besides the effects of hyperthyroidism on venous thromboembolism, its effects on embolism secondary to atrial fibrillation are described.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Elbers LPB, Fliers E, Cannegieter SC, et al. The influence of thyroid function on the coagulation system and its clinical consequences. J Thromb Haemost. 2018. PMID: 29573126. doi:10.1111/jth.13970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。